Cancer Research

How Do Antimicrobial Peptides Kill Bacterial Cells?
Research & Development How Do Antimicrobial Peptides Kill Bacterial Cells?

What if a microscopic weapon, hidden within the human body, could be the key to defeating one of the deadliest health threats of modern times—antibiotic-resistant bacteria, which claim millions of lives each year due to infections that no longer respond to traditional treatments? This urgent crisis

Genetic Risk Score Predicts Breast Cancer Progression
Research & Development Genetic Risk Score Predicts Breast Cancer Progression

Imagine a world where a simple test could predict whether abnormal breast tissue will develop into invasive breast cancer, sparing countless women from unnecessary treatments and anxiety. This vision is becoming a reality thanks to pioneering research from leading institutions that have developed

How Do Hypoxia and EUDAL Drive Oral Cancer Resistance?
Research & Development How Do Hypoxia and EUDAL Drive Oral Cancer Resistance?

Imagine a battlefield within the human body where oral cancer, a devastating form of head and neck cancer impacting hundreds of thousands globally each year, relentlessly adapts to survive against modern medical interventions. Despite significant advancements in surgery, radiation, and

How Does COOKIE-Pro Revolutionize Safer Drug Design?
Research & Development How Does COOKIE-Pro Revolutionize Safer Drug Design?

In the ever-evolving field of pharmaceutical development, the quest for safer and more effective drugs remains a critical challenge, especially when it comes to covalent inhibitors—a class of drugs known for their potent action but also their potential for harmful side effects. A groundbreaking

Digital Tools Boost Genetic Counseling for Young Cancer Survivors
Research & Development Digital Tools Boost Genetic Counseling for Young Cancer Survivors

I'm thrilled to sit down with Ivan Kairatov, a biopharma expert with a wealth of knowledge in technology and innovation within the industry. With his extensive background in research and development, Ivan offers unique insights into the groundbreaking AYA ACCESS study, which explores how digital

Two Decades of NK Cell Therapy for AML: Progress and Challenges
Research & Development Two Decades of NK Cell Therapy for AML: Progress and Challenges

For over 20 years, the medical community has been exploring innovative ways to combat acute myeloid leukemia (AML), a devastating blood cancer notorious for its aggressive progression and high relapse rates despite treatments like chemotherapy and stem cell transplantation. Among the most promising

Loading

Subscribe to our weekly news digest.

Join now and become a part of our fast-growing community.

Invalid Email Address
Thanks for Subscribing!
We'll be sending you our best soon!
Something went wrong, please try again later